Literature DB >> 15334987

Reboxetine: a norepinephrine selective reuptake pump inhibitor.

Sheldon H Preskorn1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15334987     DOI: 10.1097/00131746-200401000-00006

Source DB:  PubMed          Journal:  J Psychiatr Pract        ISSN: 1527-4160            Impact factor:   1.325


× No keyword cloud information.
  8 in total

1.  Profound weight loss associated with reboxetine use in a 44-year-old woman.

Authors:  T Y-T Lu; A Kupa; G Easterbrook; A A Mangoni
Journal:  Br J Clin Pharmacol       Date:  2005-08       Impact factor: 4.335

2.  Enhancement of Aggression Induced by Isolation Rearing is Associated with a Lack of Central Serotonin.

Authors:  Yiqiong Liu; Yunong Sun; Xiaoyan Zhao; Ji-Young Kim; Lu Luo; Qian Wang; Xiaolu Meng; Yonghui Li; Nan Sui; Zhou-Feng Chen; Chuxiong Pan; Liang Li; Yan Zhang
Journal:  Neurosci Bull       Date:  2019-04-11       Impact factor: 5.203

3.  Estimation of binding rate constants using a simultaneous mixed-effects method: application to monoamine transporter reuptake inhibitor reboxetine.

Authors:  Neil Benson; Nelleke Snelder; Bart Ploeger; Carolyn Napier; Harriet Sale; Nigel J M Birdsall; Richard P Butt; Piet H van der Graaf
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

Review 4.  Efficacy and safety of drugs for attention deficit hyperactivity disorder in children and adolescents: a network meta-analysis.

Authors:  Sarah C O S Padilha; Suzane Virtuoso; Fernanda S Tonin; Helena H L Borba; Roberto Pontarolo
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-02-19       Impact factor: 4.785

5.  Comparing Pharmacological Modulation of Sensory Gating in Healthy Humans and Rats: The Effects of Reboxetine and Haloperidol.

Authors:  Louise Witten; Jesper Frank Bastlund; Birte Y Glenthøj; Christoffer Bundgaard; Björn Steiniger-Brach; Arne Mørk; Bob Oranje
Journal:  Neuropsychopharmacology       Date:  2015-07-01       Impact factor: 7.853

Review 6.  Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials.

Authors:  Dirk Eyding; Monika Lelgemann; Ulrich Grouven; Martin Härter; Mandy Kromp; Thomas Kaiser; Michaela F Kerekes; Martin Gerken; Beate Wieseler
Journal:  BMJ       Date:  2010-10-12

7.  Catecholaminergic and opioidergic system mediated effects of reboxetine on diabetic neuropathic pain.

Authors:  Nazlı Turan Yücel; Özgür Devrim Can; Ümide Demir Özkay
Journal:  Psychopharmacology (Berl)       Date:  2020-01-07       Impact factor: 4.530

8.  Antidepressants in the treatment of fibromyalgia.

Authors:  Chantal Moret; Mike Briley
Journal:  Neuropsychiatr Dis Treat       Date:  2006-12       Impact factor: 2.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.